What it's for (Indications)
- This combination medication, containing aluminium hydroxide, magnesium hydroxide, and simethicone, is primarily indicated for the symptomatic relief of conditions associated with gastric hyperacidity.
- These conditions include heartburn, acid indigestion, sour stomach, and acid reflux, which are common manifestations of gastroesophageal reflux disease (GERD).
- It is also frequently utilized in the management of symptoms related to peptic ulcer disease, gastritis, esophagitis, and hiatal hernia.
- The inclusion of simethicone specifically addresses uncomfortable symptoms such as bloating, fullness, and abdominal discomfort caused by excessive gas accumulation, by facilitating the dispersion of gas bubbles within the gastrointestinal tract.
- This formulation offers a multifaceted approach to gastric discomfort, providing both acid neutralization and gas relief, thereby enhancing patient comfort and alleviating acute episodes of dyspepsia and flatulence.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The appropriate dosage of aluminium hydroxide + magnesium hydroxide + simethicone suspension typically varies based on the specific product concentration and individual patient needs, and should always be followed as per physician's instructions or package insert. Generally, for adults and children over 12 years of age, the usual dose is 10-20 mL (or 1-2 teaspoonfuls/tablespoonfuls, depending on formulation) taken orally, approximately 20 minutes to 1 hour after meals and at bedtime, or as needed for symptoms. It is crucial to shake the bottle well before each use to ensure uniform suspension of active ingredients. Patients should not exceed the maximum recommended daily dose, which is typically specified on the product label, and avoid continuous use for more than two weeks without consulting a healthcare professional to rule out more serious underlying conditions that may require specific medical intervention. Pediatric dosing for younger children should strictly be guided by a pediatrician. |
Safety & Warnings
Common Side Effects
- While generally well-tolerated when used as directed, aluminium hydroxide + magnesium hydroxide + simethicone can be associated with certain side effects.
- Gastrointestinal disturbances are the most common.
- Aluminium hydroxide can induce constipation, while magnesium hydroxide often has a laxative effect, and these two components are typically balanced to minimize significant changes in bowel habits.
- However, some individuals may still experience mild constipation or diarrhea, abdominal cramping, nausea, vomiting, or a chalky taste in the mouth.
- Prolonged or excessive use, particularly in individuals with impaired renal function, can lead to more serious issues such as hypermagnesemia (symptoms include muscle weakness, hypotension, central nervous system depression) and hypophosphatemia (due to aluminium's phosphate binding properties, leading to symptoms like muscle weakness, bone pain, and fatigue).
- Simethicone is largely inert and rarely causes systemic side effects due to its minimal systemic absorption.
- Allergic reactions, though rare, may manifest as rash, itching, swelling, severe dizziness, or trouble breathing, and require immediate medical attention.
Serious Warnings
- Black Box Warning: This specific combination product containing aluminium hydroxide, magnesium hydroxide, and simethicone, as an over-the-counter antacid and antiflatulent, does not carry a formal FDA Black Box Warning. However, healthcare professionals and patients should be aware of several **Serious Warnings** associated with its use, particularly under certain conditions. Prolonged use (typically exceeding two weeks) without medical supervision is strongly discouraged, as this can mask symptoms of more serious underlying gastrointestinal pathologies, such as gastric ulcers, malignancies, or chronic acid reflux disease, which require specific diagnosis and targeted medical treatment. Patients with severe renal impairment are at a significantly increased risk of hypermagnesemia, characterized by symptoms like muscle weakness, hypotension, respiratory depression, and central nervous system depression, and aluminium toxicity, potentially leading to osteomalacia and encephalopathy. Therefore, renal function should be assessed in these patients prior to and during treatment to mitigate these serious risks. Additionally, significant drug interactions can occur, where the antacid components can impair the absorption of many other concurrently administered medications, including but not limited to, tetracyclines, fluoroquinolones, iron salts, digoxin, and levothyroxine. A separation of administration by at least 2-4 hours is generally recommended to mitigate these interactions, ensuring the therapeutic efficacy of other vital medications and preventing potential treatment failures.
- Patients with pre-existing renal impairment must exercise extreme caution when using this medication, as the accumulation of magnesium can lead to hypermagnesemia, and aluminium can accumulate, potentially causing osteomalacia, encephalopathy, or dementia in chronic use.
- Long-term, high-dose use of aluminium-containing antacids can also lead to hypophosphatemia, necessitating regular monitoring of phosphate levels in vulnerable patients.
- This medication should not be used as a primary treatment for serious underlying conditions such as appendicitis, bowel obstruction, or undiagnosed severe abdominal pain, as it can mask critical symptoms and delay appropriate diagnosis.
- Pregnant and breastfeeding individuals should consult their healthcare provider before use, although antacids are generally considered low risk when used short-term.
- Due to potential drug interactions, this antacid should be administered at least 2 hours before or after other medications, particularly tetracyclines, fluoroquinolones, iron supplements, digoxin, and thyroid hormones, to prevent impaired absorption of these drugs.
- Discontinue use and consult a physician if symptoms persist for more than two weeks or worsen.
How it Works (Mechanism of Action)
The therapeutic efficacy of this combination medication stems from the synergistic actions of its three active components. Aluminium hydroxide and magnesium hydroxide function as antacids, directly neutralizing existing gastric acid (hydrochloric acid) in the stomach. Aluminium hydroxide reacts with HCl to form aluminium chloride and water, while magnesium hydroxide reacts to form magnesium chloride and water. This neutralization effect rapidly increases gastric pH, thereby reducing acidity and alleviating symptoms of heartburn and indigestion. Aluminium hydroxide also possesses mild astringent and constipating properties, whereas magnesium hydroxide acts as a mild osmotic laxative. These opposing effects often balance each other, leading to fewer significant changes in bowel habits. Simethicone, an antiflatulent agent, acts by reducing the surface tension of gas bubbles within the gastrointestinal tract. This action causes smaller gas bubbles to coalesce into larger, more easily passable bubbles, thus relieving discomfort, bloating, and pressure associated with trapped gas and flatulence without being absorbed systemically, ensuring localized action within the GI tract.
Commercial Brands (Alternatives)
No other brands found for this formula.